These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18694645)

  • 1. Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hattori K; Miyazaki T; Ogino S; Orita M; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Sep; 16(17):7968-74. PubMed ID: 18694645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hamaguchi W; Yamasaki S; Koganemaru Y; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2009 Jan; 17(1):64-73. PubMed ID: 19081254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Jul; 16(14):7021-32. PubMed ID: 18539035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of CCR4 antagonists: side-chain exploration.
    Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.
    Newhouse B; Allen S; Fauber B; Anderson AS; Eary CT; Hansen JD; Schiro J; Gaudino JJ; Laird E; Chantry D; Eberhardt C; Burgess LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5537-42. PubMed ID: 15482919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
    Liu H; Altenbach RJ; Carr TL; Chandran P; Hsieh GC; Lewis LG; Manelli AM; Milicic I; Marsh KC; Miller TR; Strakhova MI; Vortherms TA; Wakefield BD; Wetter JM; Witte DG; Honore P; Esbenshade TA; Brioni JD; Cowart MD
    J Med Chem; 2008 Nov; 51(22):7094-8. PubMed ID: 18983139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
    Park H; Kim YJ; Hahn JS
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6345-9. PubMed ID: 17869098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core exploration in optimization of chemokine receptor CCR4 antagonists.
    Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR study of acridine, 2-methylquinoline and 2-phenylquinazoline analogues as anti-prion agents.
    Cope H; Mutter R; Heal W; Pascoe C; Brown P; Pratt S; Chen B
    Eur J Med Chem; 2006 Oct; 41(10):1124-43. PubMed ID: 16782236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
    Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
    Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists.
    Storelli S; Verdijk P; Verzijl D; Timmerman H; van de Stolpe AC; Tensen CP; Smit MJ; De Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2910-3. PubMed ID: 15911279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.
    Napier SE; Letourneau JJ; Ansari N; Auld DS; Baker J; Best S; Campbell-Wan L; Chan JH; Craighead M; Desai H; Goan KA; Ho KK; Hulskotte EG; MacSweeney CP; Milne R; Morphy JR; Neagu I; Ohlmeyer MH; Peeters AW; Presland J; Riviello C; Ruigt GS; Thomson FJ; Zanetakos HA; Zhao J; Webb ML
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1871-5. PubMed ID: 21353540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis.
    Shukla L; Ajram LA; Begg M; Evans B; Graves RH; Hodgson ST; Lynn SM; Miah AH; Percy JM; Procopiou PA; Richards SA; Slack RJ
    Eur J Med Chem; 2016 Jun; 115():14-25. PubMed ID: 26991939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the interactions between lactam analogs and the N-terminal extracellular tail of CC chemokine receptor 4 by CZE.
    Sun Z; Ling X; Sun W; Xiao J; Yin C; Wang Y
    Electrophoresis; 2007 Aug; 28(17):3064-9. PubMed ID: 17668450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists.
    Letourneau JJ; Riviello CM; Li H; Cole AG; Ho KK; Zanetakos HA; Desai H; Zhao J; Auld DS; Napier SE; Thomson FJ; Goan KA; Morphy JR; Ohlmeyer MH; Webb ML
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5394-7. PubMed ID: 20719508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4.
    Wang Y; Zhang Y; Han W; Li D; Tian L; Yin C; Ma D
    Int J Biochem Cell Biol; 2008; 40(5):909-19. PubMed ID: 18069042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of the new orally active CCR4 antagonist K327 on CCR4+CD4+ T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation.
    Sato T; Komai M; Iwase M; Kobayashi K; Tahara H; Ohshima E; Arai H; Miki I
    Pharmacology; 2009; 84(3):171-82. PubMed ID: 19713720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of thiourea derivatives and carbonyl-2-aminothiazole derivatives for potential CCR4 antagonists using capillary zone electrophoresis.
    Zhang S; Qi H; Yakufu P; Zhao F; Ling X; Xiao J; Wang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):75-82. PubMed ID: 21144808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.